202 Relationship of the International Prostate Symptom Score with urinary flow studies, and catherization rates following iodine 125 prostate brachytherapy

2005 ◽  
Vol 76 ◽  
pp. S59-S60
Author(s):  
C. Martens ◽  
D. Webster ◽  
G. Pond ◽  
J. Crook
Brachytherapy ◽  
2006 ◽  
Vol 5 (1) ◽  
pp. 9-13 ◽  
Author(s):  
Chandra Martens ◽  
Greg Pond ◽  
Dennis Webster ◽  
Michael McLean ◽  
Caitlin Gillan ◽  
...  

2016 ◽  
Vol 11 (1) ◽  
pp. 158-163 ◽  
Author(s):  
Orhan Ünal Zorba ◽  
Hakkı Uzun ◽  
Görkem Akça ◽  
Selim Yazar

Because various criteria are used to define metabolic syndrome (MetS), this study examines the most relevant definition for patients with benign prostatic enlargement (BPE). Most studies regarding the link between MetS and BPE/lower urinary tract symptoms (LUTS) have used the National Cholesterol Education Program Adult Treatment Panel III criteria for diagnosis, while a few have used criteria from the International Diabetes Federation and/or American Heart Association. Patients with LUTS due to BPE are classified as having MetS or not by the aforementioned three definitions. Prostate volume, International Prostate Symptom Score, storage and voiding subscores, maximum urinary flow rate, and the postvoid urine of patients with and without MetS were compared separately in the three different groups. Surgical and medical treatment prevalence was also compared between three groups. No matter which definition was used, the International Prostate Symptom Score, the storage and voiding symptom scores, prostate volume, prostate-specific antigen, and postvoid urine were significantly higher in the patients with MetS. The maximum urinary flow rate was similar between patients with and without MetS, according to all three different definitions. There was no significant difference in the aforementioned parameter between patients with MetS diagnosed with the three different definitions. Irrespective of which definition was used, the surgical treatment rate was not significantly different in patients diagnosed with than without MetS, or between the patients with MetS diagnosed with the three different definitions. The authors suggest that it does not matter which of the aforementioned three definitions is used during the evaluation of MetS in men with BPE/LUTS.


2021 ◽  
Vol 8 (3) ◽  
pp. 1-4
Author(s):  
Prashant Patel ◽  
Krunal Patel

Background: The ‘gold standard’ surgical treatment of clinically obstructive BPH is TURP, but life-threatening complications such as transurethral resection syndrome are occasionally observed. This has traditionally been provided as monopolar TURP, but morbidity associated with MTURP has led to the introduction of other surgical techniques. Objectives: To compare the effects of bipolar and monopolar TURP. Methods: In this prospective comparative study, 50 patients of each group undergo transurethral resection of prostate were enrolled and randomized to surgery by M‑TURP or B-TURP. International Prostate Symptom Score (IPSS), uroflowmetry, ultrasonography, prevoid, postvoid and international prostate symptom score (IPSS), maximum urinary flow rate (Qmax), postvoid residual urine (PVRU) volume, and prostate volume (PV). Complications and sequelae also assessed. Comparisons performed. Results:No significant differences found in baseline characteristics or operative data, No differences found in IPSS, Qmax or PVRU volume. Conclusions:Based on this controlled trial, there is not significant variation in effectiveness and safety between M-TURP and Bipolar -TURP for the treatment of BPH. Accordingly, M-TURP continues to be a valid option for the treatment of BPE. Keywords: Transurethral resection of prostate, Monopolar, Bipolar.


2006 ◽  
Vol 97 (1) ◽  
pp. 62-68 ◽  
Author(s):  
SARAH GUTMAN ◽  
GREGORY S. MERRICK ◽  
WAYNE M. BUTLER ◽  
KENT E. WALLNER ◽  
ZACHARIAH ALLEN ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document